Li Pengxiang, Lv Xuefeng, Liu Lu, Peng Mengle, Qin Dongchun
Department of Clinical Laboratory, Key Laboratory of Laboratory Medicine of Zhengzhou Province The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.
Department of Clinical Laboratory, People's Hospital of Henan University of Chinese Medicine, Zhengzhou 450003, Henan, China.
J Oncol. 2022 Oct 30;2022:7835698. doi: 10.1155/2022/7835698. eCollection 2022.
Ferroptosis, a form of cell death driven by iron-dependent lipid peroxidation, may be a potential treatment for many cancers, including cervical cancer (CC). However, the regulation of long noncoding RNAs (lncRNAs) in the process of ferroptosis and whether ferroptosis inducers could increase the cytotoxicity of conventional chemotherapy drugs remain to be further elucidated.
We analyzed the variation of 55 differentially ferroptosis-related genes (FRGs) and the influence of mutations in CC patients. The patients with CC were classified into two ferroptosis clusters by the non-negative matrix factorization (NMF) algorithm. The principal components analysis (PCA) was used to measure the ferroptosis score (FerroScore) in patients with CC. Besides, FerroScore was used to predict the sensitivity of chemotherapy and responses to immunotherapy in patients with CC. Finally, experiments were performed to verify the regulatory effect of AC026790.1 on erastin-induced ferroptosis, as well as the effect of erastin in combination with cisplatin on the toxicity of CC cells (SiHa, HeLa).
There were significant differences in the overall survival and immune cell infiltration between the two ferroptosis clusters. Patients with low FerroScore were more sensitive to chemotherapy drugs such as cisplatin and docetaxel. The low-FerroScore group had higher CD8+ T cell infiltration and immune checkpoint expression, demonstrating that patients with lower FerroScores were more sensitive to immunotherapy, which was consistent with the result of the submap method. In vitro, overexpression of AC026790.1 could promote erastin-induced ferroptosis, and the combination of erastin and cisplatin could increase the toxicity of CC cells.
FerroScore has a potential prognostic value for CC that may provide a reference for chemotherapy and immunotherapy. LncRNA AC026790.1 can influence ferroptosis, and the combination of ferroptosis inducers and chemotherapy drugs can provide a new perspective on cancer treatment.
铁死亡是一种由铁依赖性脂质过氧化驱动的细胞死亡形式,可能是包括宫颈癌(CC)在内的许多癌症的潜在治疗方法。然而,长链非编码RNA(lncRNAs)在铁死亡过程中的调控以及铁死亡诱导剂是否能增加传统化疗药物的细胞毒性仍有待进一步阐明。
我们分析了55个差异铁死亡相关基因(FRGs)的变异情况及其在CC患者中的突变影响。采用非负矩阵分解(NMF)算法将CC患者分为两个铁死亡簇。主成分分析(PCA)用于测量CC患者的铁死亡评分(FerroScore)。此外,FerroScore用于预测CC患者对化疗的敏感性和免疫治疗反应。最后,进行实验验证AC026790.1对埃拉司亭诱导的铁死亡的调控作用,以及埃拉司亭与顺铂联合对CC细胞(SiHa、HeLa)毒性的影响。
两个铁死亡簇之间的总生存期和免疫细胞浸润存在显著差异。低FerroScore的患者对顺铂和多西他赛等化疗药物更敏感。低FerroScore组的CD8 + T细胞浸润和免疫检查点表达更高,表明FerroScore较低的患者对免疫治疗更敏感,这与亚图方法的结果一致。在体外,AC026790.1的过表达可促进埃拉司亭诱导的铁死亡,且埃拉司亭与顺铂联合可增加CC细胞的毒性。
FerroScore对CC具有潜在的预后价值,可为化疗和免疫治疗提供参考。LncRNA AC026790.1可影响铁死亡,铁死亡诱导剂与化疗药物联合可为癌症治疗提供新的视角。